E.U. Targets AstraZeneca In Crackdown On Patent Abuse
In the first European antitrust crackdown on patent abuse, the European Commission is expected to fine AstraZeneca on Wednesday for systematically exploiting patent regulations to thwart generic competition....To view the full article, register now.
Already a subscriber? Click here to view full article